(NewsDirect)
Herborium Group,Inc. (HBRN) is a botanical therapeutics® company that addressesdermatological and other health and wellness concerns via itsproprietary medicinal products that are supported by science-centeredcontent.
In anexclusive interview with the Capital Gains Report, HBRN CEO Dr. AgnesOlszewski discussed the company’s track to take advantage ofpromising opportunities arising in the natural segment of the wellnessindustry, particularly as it applies to skincare, and an importantboost to this area of the market can get from the application ofartificial intelligence.
HBRN’s Approach of Integrating Medicine andBeauty
Theglobal natural cosmetics market is growing at a fast pace and isprojected to reach $79.6 billion by 2033, with an annual growth rateof 5.1%. This rise is driven by the emergence of a new category ofadvanced, natural ingredient-based products available via conventionalretail channels and online retailers, as well as the growingprominence of safer and more efficacious science-based beauty andwellness culture, which fuels the accelerated demand for naturalbeauty products.
Dr. Olszewski said, “One of the most important trends in thehealthcare and beauty sectors is the merger of clinical skincare withnatural skincare to create safe and validated “hybrid” productsthat actually work while maintaining their natural ingredientprofile.”
Herborium’s acne treatment represents such a unique product.AcnEase is a systemic, all botanical ingredient-based, proprietary,clinically tested acne treatment for teen and adult acne, that alsoimproves symptoms of an inflammatory skin condition called rosacea.
Dr. Olszewskisaid, “We are presently working on the second generation of thisclinically validated skincare solution that has better consumercharacteristics -- broader application and simpler treatment routine-- and improved business profile, such as increased margins. Thecompany is also approaching the most advanced science in clinicalskincare - stem cell-based products. We are working to add two highlyinnovative products in this category to our 2023 and 2024 productportfolios.”
The company pursues a cross-sectoral approach, aiming to useclinical testing in order to integrate pharmaceutical andnutraceutical market segments.
Exploring the Power of Artificial Intelligencein Natural Skincare Sector
Another strength of HBRM has to do with the use ofpioneering technology as applied to the development of naturalskincare products and a total solution that would address consumerconcerns in the skincare sector. On May 11, 2023, the companyannounced signing a Letter of Intent with Adrecom, a US-basedtechnology and e-commerce company with offices in North Carolina andCalifornia, to purchase and further advance AI technology that willpower HBRM's natural skin health and wellness platform. Itcompleted the first stage of designing this platform and is currentlyin the midst of testing and further advancing it.
Dr. Olszewski says,“Herborium’s unique approach is the active use of technology inthe natural segment of skincare and skin wellness.” The AI platformwill deliver streamlined and more precise diagnosis, curated,personalized skincare counseling, products, and other related servicessuch as nutrition and esthetician-provided recommendations.
This step positions HBRMas a frontrunner in the novel skincare industry, opening up new waysfor innovation and potential revenue streams. “Our AI-based platformoffers an integrated, personalized approach to skincare and skinhealth,” says Dr. Olszewski. “At the moment, an integratedplatform for natural skincare and skin wellness does notexist.”
Asmedicine and wellness develop in parallel with advancements in usingAI technology to support a personalized approach to treatments andmore common wellness and beauty solutions, HBRM is a first mover inthis space as it is capable of combining its natural ingredient-basedproducts and relevant, cutting edge content with advanced AItechnology.
Growth through Partnerships
HBRM is currently commercializing itsproducts and has already established a strong presence in the UnitedStates, the United Kingdom, and continental Europe through a networkof specialty retailers, distributors, and e-commerce platforms.
With a well-establishedcustomer base and strong brand recognition, the company plans toestablish new sales targets by building curated partnerships withother product originators. “We are presently in advanced talks withtwo companies—one from the US and a second from South Korea that arewell known in the cosmetic and skin wellness industry for high-qualitybiotechnological applications in skincare,” says Dr.Olszewski.
Conclusion
Natural ingredients and the potential for an AI-drivenpersonalized approach to skincare mean that Herborium’s productshave the potential to gain popularity with consumers quickly. They arecapable of connecting medical and beauty applications with a focus onnatural ingredients, filling an important gap in the market.
Disclaimers: CapitalGainsReport (CGR) is notoperated by a licensed broker, a dealer, or a registered investmentadviser. This content is for informational purposes only and is notintended to be investment advice. The Private Securities LitigationReform Act of 1995 provides investors a safe harbor in regard toforward-looking statements. Any statements that express or involvediscussions with respect to predictions, expectations, beliefs, plans,projections, objectives, goals, assumptions, or future events orperformance are not statements of historical fact may be forwardlooking statements. Forward looking statements are based onexpectations, estimates, and projections at the time the statementsare made that involve a number of risks and uncertainties which couldcause actual results or events to differ materially from thosepresently anticipated. Forward looking statements in this action maybe identified through use of words such as projects, foresee, expects,will, anticipates, estimates, believes, understands, or that bystatements indicating certain actions & quote; may, could, ormight occur. Understand there is no guarantee past performance will beindicative of future results. Investing in micro-cap and growthsecurities is highly speculative and carries an extremely high degreeof risk. It is possible that an investors investment may be lost orimpaired due to the speculative nature of the companies profiled.CapitalGainsReport (CGR) has been retained by Herborium to assist inthe production and distribution of content. 'CGR' isresponsible for the production and distribution of this content. Itshould be expressly understood that under no circumstances does anyinformation published herein represent a recommendation to buy or sella security. This content is for informational purposes only, youshould not construe any such information or other material as legal,tax, investment, financial, or other advice. Nothing contained in thisarticle constitutes a solicitation, recommendation, endorsement, oroffer by CapitalGainsReport or any third party service provider to buyor sell any securities or other financial instruments. All content inthis article is information of a general nature and does not addressthe circumstances of any particular individual or entity. Nothing inthis article constitutes professional and/or financial advice, nordoes any information in the article constitute a comprehensive orcomplete statement of the matters discussed or the law relatingthereto. CGR is not a fiduciary by virtue of any persons use of oraccess to this content.
ContactDetails
Capital Gains Report
MarkMcKelvie
+1 585-301-7700
CompanyWebsite
Copyright (c) 2023 TheNewswire - All rights reserved.